← FDA Drug Approvals (Drugs@FDA)
SUCCINYLCHOLINE CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2025-02-11
Drug application
- FDA Application #
ANDA217884- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUCCINYLCHOLINE CHLORIDE
- Generic name
- SUCCINYLCHOLINE CHLORIDE
- Active ingredients
- SUCCINYLCHOLINE CHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA LLC
- First approval
- 2025-02-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown